Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.39151 | 78 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.82689 | 81 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.59481 | 80 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.67016 | 79 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 5.77771 | 81 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.59548 | 81 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.44235 | 79 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.5638 | 80 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.60905 | 80 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 5.89089 | 81 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 6.27924 | 84 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 5.99061 | 82 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 6.06269 | 83 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 5.9381 | 82 |